Related Articles
Cell cycle checkpoint control: The cyclin G1/Mdm2/p53 axis emerges as a strategic target for broad‑spectrum cancer gene therapy - A review of molecular mechanisms for oncologists
Impact on breast cancer susceptibility and clinicopathological traits of common genetic polymorphisms in <em>TP53</em>, <em>MDM2</em> and <em>ATM</em> genes in Sardinian women
INCREASED MDM2 EXPRESSION AND IMMUNOREACTIVITY IN HUMAN PANCREATIC DUCTAL ADENOCARCINOMA
UBE2K regulated by IGF2BP3 promotes cell proliferation and stemness in pancreatic ductal adenocarcinoma
High mobility group AT‑hook 2 and c‑MYC as potential prognostic factors in pancreatic ductal adenocarcinoma